Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg

ClinicalTrials.gov ID: NCT02091986

Public ClinicalTrials.gov record NCT02091986. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 5:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose is to investigate the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared with Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to \<12 Years with Asthma during 12 weeks.

Study identification

NCT ID
NCT02091986
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
882 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
6 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2014 (Type not available)
Primary completion
Apr 2016 (Actual)
Completion
Apr 2016 (Actual)
Last update posted
Apr 10, 2017

2014 – 2016

United States locations

U.S. sites
59
U.S. states
24
U.S. cities
59
Facility City State ZIP Site status
Research Site Hoover Alabama — —
Research Site Montgomery Alabama — —
Research Site Gilbert Arizona — —
Research Site Little Rock Arkansas — —
Research Site Huntington Beach California — —
Research Site Long Beach California — —
Research Site Mission Viejo California — —
Research Site Newport Beach California — —
Research Site Ontario California — —
Research Site Stockton California — —
Research Site Walnut Creek California — —
Research Site Colorado Springs Colorado — —
Research Site Denver Colorado — —
Research Site Aventura Florida — —
Research Site Coral Gables Florida — —
Research Site Fort Walton Beach Florida — —
Research Site Hialeah Florida — —
Research Site Homestead Florida — —
Research Site Jacksonville Florida — —
Research Site Largo Florida — —
Research Site Miami Florida — —
Research Site Williston Florida — —
Research Site Winter Park Florida — —
Research Site Savannah Georgia — —
Research Site Stockbridge Georgia — —
Research Site Lenexa Kansas — —
Research Site Waldorf Maryland — —
Research Site Plymouth Minnesota — —
Research Site Bellevue Nebraska — —
Research Site Verona New Jersey — —
Research Site Albuquerque New Mexico — —
Research Site Rockville Centre New York — —
Research Site Watertown New York — —
Research Site Charlotte North Carolina — —
Research Site Canton Ohio — —
Research Site Cincinnati Ohio — —
Research Site Toledo Ohio — —
Research Site Edmond Oklahoma — —
Research Site Oklahoma City Oklahoma — —
Research Site Gresham Oregon — —
Research Site Medford Oregon — —
Research Site Portland Oregon — —
Research Site Upland Pennsylvania — —
Research Site North Charleston South Carolina — —
Research Site Spartanburg South Carolina — —
Research Site West Columbia South Carolina — —
Research Site Allen Texas — —
Research Site Baytown Texas — —
Research Site El Paso Texas — —
Research Site Fort Worth Texas — —
Research Site Houston Texas — —
Research Site Kerville Texas — —
Research Site Richmond Texas — —
Research Site San Antonio Texas — —
Research Site Waco Texas — —
Research Site Murray Utah — —
Research Site Fairfax Virginia — —
Research Site Tacoma Washington — —
Research Site Washington Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02091986, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 10, 2017 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02091986 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →